Systematic Review: Telemedicine dalam Manajemen Pasien Gagal Jantung semasa Pandemi

https://doi.org/10.22146/jkesvo.62300

Sidhi Laksono(1*), Anhari Achadi(2), Reynaldo Halomoan(3)

(1) Fakultas Kesehatan Masyarakat, Universitas Indonesia
(2) Fakultas Kesehatan Masyarakat, Universitas Indonesia
(3) Fakultas Kedokteran dan Ilmu Kesehatan, Universitas Katolik Indonesia Atma Jaya
(*) Corresponding Author

Abstract


Latar Belakang: Pandemi global COVID-19 menjadi hambatan bagi kunjungan pasien gagal jantung ke rumah sakit. Untuk itu, telemedicine yang memanfaatkan teknologi dan dapat mengurangi kontak fisik antara dokter dengan pasien dapat menjadi solusi bagi manajemen pasien. Telemedicine juga memiliki potensi untuk memberikan keluaran yang baik bagi pasien.

Tujuan: Mengevaluasi dampak telemedicine dalam perawatan pasien gagal jantung.

Metode: Pencarian komprehensif menggunakan kata kunci dilakukan dari 2 basis data selama tahun 2000-2020 untuk mengidentifikasi studi mengenai penerapan telemedicine pada manajemen pasien gagal jantung. Setelah itu, dilakukan penilaian risiko bias dan ekstraksi data.

Hasil: Terdapat 2 uji coba terkontrol secara acak dan 2 studi kohort prospektif yang dikaji. Tiga studi menunjukkan penurunan laju hospitalisasi pada pasien gagal jantung. Untuk mortalitas, 1 studi menunjukkan penurunan yang bermakna pada kelompok pasien gagal jantung yang menjalani telemedicine. Namun, pada 1 studi lain tidak terdapat perbedaan bermakna (semua penyebab kematian). Terdapat 1 studi masing-masing yang membahas mengenai kualitas hidup dan kepatuhan berobat, dan terdapat perbedaan bermakna, sedangkan untuk biaya, 1 studi menunjukkan penurunan biaya yang dikeluarkan dan 1 studi tidak menunjukkan perbedaan bermakna.

Kesimpulan: Telemedicine memberikan manfaat terhadap keluaran pasien gagal jantung.


Keywords


telemedicine; pasien gagal jantung; keluaran pasien

Full Text:

PDF


References

Antonicelli, R., Mazzanti, I., Abbatecola, A. M., & Parati, G. (2010). Impact of Home Patient Telemonitoring on Use of β-Blockers in Congestive Heart Failure. Drugs & Aging, 27(10), 801–805. https://doi.org/10.2165/11538210-000000000-00000

Blum, K., & Gottlieb, S. S. (2014). The Effect of a Randomized Trial of Home Telemonitoring on Medical Costs, 30-Day Readmissions, Mortality, and Health-Related Quality of Life in a Cohort of Community-Dwelling Heart Failure Patients. Journal of Cardiac Failure, 20(7), 513–521. https://doi.org/10.1016/j.cardfail.2014.04.016

Comín-Colet, J., Enjuanes, C., Verdú-Rotellar, J. M., Linas, A., Ruiz-Rodriguez, P., González-Robledo, G., Farré, N., Moliner-Borja, P., Ruiz-Bustillo, S., & Bruguera, J. (2016). Impact on clinical events and healthcare costs of adding telemedicine to multidisciplinary disease management programmes for heart failure: Results of a randomized controlled trial. Journal of Telemedicine and Telecare, 22(5), 282–295. https://doi.org/10.1177/1357633X15600583

De Simone, V., Guarise, P., Guardalben, S., Padovani, N., Tondelli, S., Sandrini, D., Visentin, E., & Zanotto, G. (2020). Telecardiology during the Covid-19 pandemic: past mistakes and future hopes. American Journal of Cardiovascular Disease, 10(2), 34–47. http://www.ncbi.nlm.nih.gov/pubmed/32685262

Dendale, P., De Keulenaer, G., Troisfontaines, P., Weytjens, C., Mullens, W., Elegeert, I., Ector, B., Houbrechts, M., Willekens, K., & Hansen, D. (2012). Effect of a telemonitoring-facilitated collaboration between general practitioner and heart failure clinic on mortality and rehospitalization rates in severe heart failure: the TEMA-HF 1 (TElemonitoring in the MAnagement of Heart Failure) study. European Journal of Heart Failure, 14(3), 333–340. https://doi.org/10.1093/eurjhf/hfr144

Frederix, I., Vanderlinden, L., Verboven, A.-S., Welten, M., Wouters, D., De Keulenaer, G., Ector, B., Elegeert, I., Troisfontaines, P., Weytjens, C., Mullens, W., & Dendale, P. (2019). Long-term impact of a six-month telemedical care programme on mortality, heart failure readmissions and healthcare costs in patients with chronic heart failure. Journal of Telemedicine and Telecare, 25(5), 286–293. https://doi.org/10.1177/1357633X18774632

Gensini, G. F., Alderighi, C., Rasoini, R., Mazzanti, M., & Casolo, G. (2017). Value of Telemonitoring and Telemedicine in Heart Failure Management. Cardiac Failure Review, 3(2), 1. https://doi.org/10.15420/cfr.2017:6:2

Greenhalgh, T., A’Court, C., & Shaw, S. (2017). Understanding heart failure; explaining telehealth – a hermeneutic systematic review. BMC Cardiovascular Disorders, 17(1), 156. https://doi.org/10.1186/s12872-017-0594-2

Higgins, J. P., & Altman, D. G. (2008). Assessing Risk of Bias in Included Studies. In J. P. Higgins & S. Green (Eds.), Cochrane Handbook for Systematic Reviews of Interventions (pp. 187–241). John Wiley & Sons, Ltd. https://doi.org/10.1002/9780470712184.ch8

Knox, L., Rahman, R. J., & Beedie, C. (2017). Quality of life in patients receiving telemedicine enhanced chronic heart failure disease management: A meta-analysis. Journal of Telemedicine and Telecare, 23(7), 639–649. https://doi.org/10.1177/1357633X16660418

Kotb, A., Cameron, C., Hsieh, S., & Wells, G. (2015). Comparative Effectiveness of Different Forms of Telemedicine for Individuals with Heart Failure (HF): A Systematic Review and Network Meta-Analysis. PLOS ONE, 10(2), e0118681. https://doi.org/10.1371/journal.pone.0118681

Ramaekers, B. L. T., Janssen-Boyne, J. J., Gorgels, A. P. M., & Vrijhoef, H. J. M. (2009). Adherence Among Telemonitored Patients with Heart Failure to Pharmacological and Nonpharmacological Recommendations. Telemedicine and E-Health, 15(6), 517–524. https://doi.org/10.1089/tmj.2009.0160

Riley, W. T., Keberlein, P., Sorenson, G., Mohler, S., Tye, B., Ramirez, A. S., & Carroll, M. (2015). Program Evaluation of Remote Heart Failure Monitoring: Healthcare Utilization Analysis in a Rural Regional Medical Center. Telemedicine and E-Health, 21(3), 157–162. https://doi.org/10.1089/tmj.2014.0093

Roth, A., Kajiloti, I., Elkayam, I., Sander, J., Kehati, M., & Golovner, M. (2004). Telecardiology for patients with chronic heart failure: the ‘SHL’ experience in Israel. International Journal of Cardiology, 97(1), 49–55.  https://doi.org/10.1016/j.ijcard.2003.07.030

Savard, L. A., Thompson, D. R., & Clark, A. M. (2011). A meta-review of evidence on heart failure disease management programs: the challenges of describing and synthesizing evidence on complex interventions. Trials, 12(1), 194. https://doi.org/10.1186/1745-6215-12-194

Savarese, G., & Lund, L. H. (2017). Global Public Health Burden of Heart Failure. Cardiac Failure Review, 03(01), 7. https://doi.org/10.15420/cfr.2016:25:2

Spaeder, J., Najjar, S. S., Gerstenblith, G., Hefter, G., Kern, L., Palmer, J. G., Gottlieb, S. H., & Kasper, E. K. (2006). Rapid titration of carvedilol in patients with congestive heart failure: A randomized trial of automated telemedicine versus frequent outpatient clinic visits. American Heart Journal, 151(4), 844.e1-844.e10. https://doi.org/10.1016/j.ahj.2005.06.044

Zhu, Y., Gu, X., & Xu, C. (2020). Effectiveness of telemedicine systems for adults with heart failure: a meta-analysis of randomized controlled trials. Heart Failure Reviews, 25(2), 231–243. https://doi.org/10.1007/s10741-019-09801-5



DOI: https://doi.org/10.22146/jkesvo.62300

Article Metrics

Abstract views : 2284 | views : 2763

Refbacks

  • There are currently no refbacks.




Copyright (c) 2021 Jurnal Kesehatan Vokasional

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.


site
stats View My Stats